Based on the fact that prolonged dyslipidemia due to the chronic inflammatory process led to atherosclerotic plaque formation and an elevated risk of cardiovascular accidents, some studies suggested measuring of inflammatory markers such as CRP to assess cardiovascular risk [29, 30]. Here, CRP is linked to metabolic syndrome.